How plague-causing bacteria disarm host defense

May 24, 2007

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system. In essence, they knock down the front door of resistance and disarm the cell's alarm system.

Now, researchers at the University of California, San Diego (UCSD) School of Medicine have identified a novel molecular target for an effector protein called YpkA, one of several effectors of the bacteria Yersinia – the pathogen responsible for the Middle Ages' "Black Death" and a virulent form of food poisoning today. Their study will be published online in the May 25 issue of Molecular Cell.

YpkA targets a host protein called Gaq, the messenger that transmits extracellular signals ("we are under attack!") into the host cell, so that it can mount a defense.

"The alarm signal sent by Gaq is intercepted by YpkA, which sets up a roadblock along several cellular pathways that Gq uses to deliver the alarm," said lead author Lorena Navarro, Ph.D., post-doctoral researcher in the lab of the study's principle investigator, Jack E. Dixon, Ph.D., professor of Pharmacology and Cellular and Molecular Medicine at the UCSD School of Medicine.

Identifying this new target is the first step to developing effective strategies for preventing disease, including means to fight antibiotic-resistant strains of Yersinia that could be used in biological warfare, according to Navarro.

The genus Yersinia includes three species of bacteria that are pathogenic to humans: Y. pestis is perhaps the most infamous, being responsible for the bubonic plague (also known as the Black Death), which killed more than 200 million people in the Middle Ages.

"This bacterial species could still be a threat today," said Navarro, adding that scientists had isolated an antibiotic-resistant strain of this species. In addition Y. pseudotuberculosis and Y. enterocolitica are big words for nasty, little bugs that cause what's commonly known as food poisoning. All three bacteria species find their way past the body's immune system through a sophisticated invasion system that injects the effector proteins directly into the host cell's cytoplasm.

"More than a decade after its discovery, our understanding of YpkA is still incomplete," Navarro said. "But Yersinia has maintained YpkA over millions of years, so it must be doing something important." The researchers speculate that YpkA plays an important role in disabling the body's immune system beyond its previously known role of disrupting the host cell's normal structure, which interferes with the cell's innate ability to engulf and destroy invading bacteria. "The question now becomes, why is Gaq targeted by YpkA?"

Source: University of California - San Diego

Explore further: Everything you wanted to know about mitochondrial mutations but were afraid to ask

add to favorites email to friend print save as pdf

Related Stories

Google delivers another earnings letdown, stock sinks

13 minutes ago

Google has gotten into the habit of missing analysts' earnings targets, frustrating investors who believe the online search leader would be more profitable it wasn't pouring so much money into far-flung projects ...

Sundance doc examines real-life Close Encounter

58 minutes ago

Earth authorities are completely unprepared for the arrival of alien visitors and worried humans should ready themselves by watching a groundbreaking documentary, the film's director boasts.

Skin device uses motion to power electronics

58 minutes ago

Can a skin patch power wearables? Skin-based generators have become an area of focus among researchers working on how to scavenge muscle motion whereby skin becomes a charge-collector. A detailed report in ...

Recommended for you

Among gut microbes, strains, not just species, matter

5 hours ago

A large community of microorganisms calls the human digestive tract home. This dynamic conglomerate of microscopic life forms - the gut microbiome - is vital to how people metabolize various nutrients in ...

Scientists develop compound to fight MRSA

5 hours ago

Microbiologists and chemists at the University of South Florida have developed and patented a synthetic compound that has shown antibiotic action against methicillin resistant Staphylococcus aureus, also k ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.